Choreo LLC’s Takeda Pharmaceutical TAK Stock Holding History

Choreo LLC’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$673K	Buy	41,957 +744	+2%	+$12.3K	0.01%	826
2026 Q1	$763K	Buy	41,213 +6,603	+19%	+$116K	0.01%	738
2025 Q4	$541K	Buy	34,610 +4,196	+14%	+$60K	0.01%	884
2025 Q3	$445K	Buy	30,414 +5,613	+23%	+$83.4K	0.01%	976
2025 Q2	$383K	Buy	24,801 +3,539	+17%	+$52.3K	0.01%	1043
2025 Q1	$316K	Buy	21,262 +1,229	+6%	+$17.2K	﹤0.01%	1064
2024 Q4	$264K	Sell	20,033 -2,952	-13%	-$40.5K	﹤0.01%	1249
2024 Q3	$328K	Buy	22,985 +543	+2%	+$7.7K	﹤0.01%	1155
2024 Q2	$292K	Buy	+22,442	New	+$297K	﹤0.01%	1111

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Choreo LLC's TAK Position: Q2 2026 in Review

Choreo LLC increased its Takeda Pharmaceutical (TAK) stake by 1.8% in Q2 2026, buying an estimated $12.3K and bringing the position to 41,957 shares worth $673K. The position accounts for 0.01% of the portfolio, ranked #826.

Choreo LLC first reported a position in TAK in Q2 2024 and has held it in 9 quarters since. The position peaked at $763K in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Choreo LLC held 41,957 shares of Takeda Pharmaceutical worth $673K as of Q2 2026.
Choreo LLC bought 744 Takeda Pharmaceutical shares in Q2 2026, an estimated $12.3K.
Takeda Pharmaceutical made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #826 holding.
Choreo LLC first reported a position in Takeda Pharmaceutical in Q2 2024 and has held it in 9 quarters since.
Choreo LLC's Takeda Pharmaceutical position peaked at $763K in Q1 2026.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.